Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Envisagenics
335 Madison Ave, 16th Floor
New York, NY 10017
Phone: 516-847-5485

Envisagenics was founded in 2014 as a spinout of Cold Spring Harbor Laboratory. The company's mission is to boost the creation of new therapies for human diseases by reducing the complexity of biomedical big data into plausible solutions. Envisagenics focuses on the discovery of RNA therapeutics. Over 30 million people in the US suffer from genetic diseases or cancer that could be caused by mutations affecting RNA splicing. 370 human diseases are known to be caused by splicing errors and more remain to be discovered.

Key Contact
Name
Maria Luisa Pineda, PhD
Title
CEO & Co-Founder
Funding Events

Date
Amount
Type
Investors
Valuation
11/28/17 $2,250,000 Seed Dynamk Capital
undisclosed
09/29/21 undisclosed Series A Dynamk Capital
M12
Madrona Venture Group
New York Ventures
Red Cell Partners
Third Kind Venture Capital
undisclosed